Indole-3-carbinol induces apoptosis in AGS cancer cells via mitochondrial pathway

Alka Ashok Singh1, Sung-Han Jo2, Anley Teferra Kiddane1

  • 1Laboratory of Cell Signaling, Department of Microbiology, College of Natural Science, Pukyong National University, Busan, Korea.

Insights

Indole-3-carbinol (I3C) induces apoptosis in human gastric cancer cells by activating the intrinsic mitochondrial pathway. This cruciferous vegetable compound shows significant anticancer potential with low toxicity, offering new strategies against oncogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Indole-3-carbinol (I3C), derived from cruciferous vegetables, is known for various biological effects.
  • The anticancer mechanisms of I3C in human gastric adenocarcinoma (AGS) cells remain largely unexplored.

Purpose of the Study:

  • To investigate the anticancer activity and molecular mechanisms of I3C in human AGS cells.
  • To evaluate I3C's effect on cell proliferation, apoptosis, and its binding affinity to apoptotic proteins.

Main Methods:

  • Cell viability assays (WST-1) and DNA fragmentation assays were used to assess cell death.
  • Quantitative PCR (qPCR) evaluated apoptosis markers and gene expression.
  • Molecular docking identified I3C's binding affinity to apoptotic protein 3DCY.

Main Results:

  • I3C significantly reduced AGS cell proliferation and viability.
  • Nuclear condensation, DNA fragmentation, and cytochrome-c release indicated apoptosis induction via the intrinsic pathway.
  • I3C demonstrated strong binding affinity for the apoptotic protein 3DCY, involving caspase activation.

Conclusions:

  • I3C effectively induces apoptosis in human gastric cancer cells through intrinsic mitochondrial pathways.
  • I3C and its metabolites exhibit broad-spectrum antitumor activity and low toxicity, suggesting potential for novel cancer therapeutic strategies.
  • I3C's mechanisms offer promising avenues for developing new approaches to decrease oncogenesis.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.7K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K